Novo Nordisk
NVO
#77
Rank
NZ$380.85 B
Marketcap
NZ$86.09
Share price
-2.25%
Change (1 day)
-20.15%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): NZ$42.76 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are NZ$51.37 Billion. In 2025 the company made an earning of NZ$35.86 Billion, an increase over its 2024 earnings that were of NZ$33.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$42.76 B19.25%
2025 NZ$35.86 B6.28%
2024 NZ$33.74 B28.01%
2023 NZ$26.35 B57.81%
2022 NZ$16.70 B5.24%
2021 NZ$15.87 B12.38%
2020 NZ$14.12 B13.11%
2019 NZ$12.48 B-3.45%
2018 NZ$12.93 B1.88%
2017 NZ$12.69 B4.3%
2016 NZ$12.17 B10.32%
2015 NZ$11.03 B7.47%
2014 NZ$10.26 B3.4%
2013 NZ$9.92 B19.09%
2012 NZ$8.33 B15.58%
2011 NZ$7.21 B16.58%
2010 NZ$6.18 B25.66%
2009 NZ$4.92 B10.68%
2008 NZ$4.44 B55.82%
2007 NZ$2.85 B7.02%
2006 NZ$2.66 B19.05%
2005 NZ$2.24 B10.55%
2004 NZ$2.02 B
2002 NZ$1.38 B-14.39%
2001 NZ$1.61 B-52.82%
2000 NZ$3.41 B250%
1999 NZ$0.97 B31.21%
1998 NZ$0.74 B34.31%
1997 NZ$0.55 B11.46%
1996 NZ$0.49 B9.03%
1995 NZ$0.45 B-3.15%
1994 NZ$0.47 B-0.67%
1993 NZ$0.47 B45.38%
1992 NZ$0.32 B-13.81%
1991 NZ$0.37 B37.12%
1990 NZ$0.27 B-0.79%
1989 NZ$0.27 B26.2%
1988 NZ$0.22 B24.97%
1987 NZ$0.17 B-0.9%
1986 NZ$0.17 B-7.78%
1985 NZ$0.19 B24.87%
1984 NZ$0.15 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.12 B-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.25 B 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.10 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$16.41 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA